BRIDGEBIO ONCOLOGY THERAPEUTICS, INC. (NASDAQ: BBOT)

BRIDGEBIO ONCOLOGY THERAPEUTICS, INC.

NASDAQ: BBOT (BridgeBio Oncology Therapeutics)

Kemas kini terakhir: 5 hari lalu, 9:36PM

11.25

-0.14 (-1.23%)

Tambah ke senarai pantauan

Penutupan Terdahulu	11.39
Buka	11.48
Jumlah Dagangan	164,264
Purata Dagangan (3B)	221,825
Modal Pasaran	899,872,768

Harga / Buku (P/B)

2.25

Julat 52 Minggu

8.50 (-24%) — 14.87 (32%)

Arah Aliran Pasaran

		Jangka Pendek	Jangka Sederhana
Industri	Biotechnology (US)	Menaik	Bercampur
	Biotechnology (Global)	Menaik	Bercampur
Stok	BridgeBio Oncology Therapeutics	Menaik	-

AISkor Stockmoo

2.0

Konsensus Penganalisis	5.0
Aktiviti Orang Dalam	NA
Volatiliti Harga	1.0
Purata Bergerak Teknikal	2.5
Osilator Teknikal	-0.5
Purata	2.00

Saham Serupa

Stok	Modal Pasaran	DY	P/E (TTM)	P/B
BBOT	900 M	-	-	2.25
BNTX	30 B	-	-	1.28
LEGN	3 B	-	-	3.79
ALMS	3 B	-	-	8.65
ELVN	2 B	-	-	3.37
BCAX	917 M	-	3.28	2.40

BridgeBio Oncology Therapeutics Inc, formerly BridgeBio Oncology Therapeutics is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes.
Sektor	Healthcare
Industri	Biotechnology

Pemilikan

Nama	Tarikh	Syer Dipegang
Eventide Asset Management, Llc	30 Sep 2025	1,082,362

Julat 52 Minggu	8.50 (-24%) — 14.87 (32%)
Julat Harga Sasaran	20.00 (77%) — 25.00 (122%)
Tinggi	25.00 (Wedbush, 122.22%)	Beli
Median	23.00 (104.44%)
Rendah	20.00 (Morgan Stanley, 77.78%)	Beli
Purata	22.75 (102.22%)
Jumlah	4 Beli
Harga Purata @ Panggilan	13.03

Syarikat	Tarikh	Harga Sasaran	Panggilan	Harga @ Panggilan
Raymond James	09 Jan 2026	24.00 (113.33%)	Beli	13.19
Wedbush	11 Dec 2025	25.00 (122.22%)	Beli	12.84
Wedbush	25 Nov 2025	25.00 (122.22%)	Beli	12.36
Morgan Stanley	05 Dec 2025	20.00 (77.78%)	Beli	13.69
Oppenheimer	13 Nov 2025	22.00 (95.56%)	Beli	12.38

Tiada data dalam julat masa ini.

Tarikh	Jenis	Butiran
13 Jan 2026	Pengumuman	BridgeBio Oncology Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
07 Jan 2026	Pengumuman	BBOT Announces New Clinical Data Advancing Its Portfolio of Three Innovative and Differentiated RAS and PI3Kα Pipeline Programs
16 Dec 2025	Pengumuman	BBOT to Present at the 44th Annual J.P. Morgan Healthcare Conference
11 Dec 2025	Pengumuman	BBOT Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
10 Dec 2025	Pengumuman	BBOT Announces Late-Breaking Preclinical Data on BBO-10203, a First-in-Class RAS:PI3Kα Breaker, at the San Antonio Breast Cancer Symposium (SABCS)
18 Nov 2025	Pengumuman	BBOT to Participate in Upcoming December Investor Healthcare Conferences
12 Nov 2025	Pengumuman	BBOT Reports Third Quarter 2025 Financial Results and Update on Corporate Progress
03 Nov 2025	Pengumuman	BBOT to Participate in the Jefferies Global Healthcare Conference in London
30 Oct 2025	Pengumuman	BBOT Announces Poster Presentations at the San Antonio Breast Cancer Symposium (SABCS)

Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.

Portfolio

Log masuk untuk menambahkan ke senarai pantauan

AI Templat

Peringatan harga anda

Harga Masuk (EP)

Ambil Untung 1 (TP1)

Ambil Untung 2 (TP2)

Henti Rugi (SL)

Log masuk untuk menambahkan ke senarai pantauan

Keuntungan Nyata	-
Keuntungan Tidak Nyata	-
Dividen Diterima 2026	-
Jumlah Untung	-
Pulangan Purata	-
Kuantiti (Beli)	-
Purata Harga (Beli)	-
Kuantiti (Jual)	-
Purata Harga (Jual)	-

Log masuk untuk menambahkan ke senarai pantauan

Tiada saham yang memenuhi kriteria anda

Margin Keselamatan (EP)
Keuntungan Separa (TP1)
Keuntungan Sasaran (TP2)
Kerugian Maksimum (SL)